Presurgical octreotide treatment in acromegaly

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1982 • 1,317 citations

Pathology of invasive pituitary tumors with special reference to functional classification

1986 • 419 citations

Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995

1985 • 396 citations

Tumors of the Pituitary Gland

1990 • 277 citations

Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients

1988 • 265 citations

Long-term Treatment of 189 Acromegalic Patients With the Somatostatin Analog Octreotide

1991 • 234 citations

The Growth Hormone Responses to Octreotide in Acromegaly Correlate with Adenoma Somatostatin Receptor Status

1989 • 212 citations

Preoperative Treatment of Acromegaly with Long-Acting Somatostatin Analog SMS 201-995: Shrinkage of Invasive Pituitary Macroadenomas and Improved Surgical Remission Rate*

1988 • 191 citations

Effect of Somatostatin in Patients with Acromegaly

1974 • 188 citations

LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALY

1984 • 187 citations

EPILEPTIC DEATH DUE TO SUFFOCATION DURING SLEEP

1970 • 174 citations

Pituitary microadenomas

1981 • 153 citations

Growth Hormone Release Inhibiting Hormone in Acromegaly

1974 • 152 citations

Long Term Effect of Incremental Doses of the Somatostatin Analog SMS 201–995 in 58 Acromegalic Patients*

1990 • 134 citations

Therapeutic Efficacy of the Somatostatin Analog SMS 201-995 (Octreotide) in Acromegaly

1990 • 133 citations

Medical Treatment of Acromegaly with SMS 201-995, a Somatostatin Analog: A Comparison with Bromocriptine*

1987 • 132 citations

Management of pituitary adenomas and related lesions with emphasis on transsphenoidal microsurgery

1983 • 97 citations

Treatment of Resistant Acromegaly with a Long-Acting Somatostatin Analogue (SMS 201-995)

1986 • 95 citations

Thyrotropin-Secreting Pituitary Adenomas: Report of Seven Cases

1991 • 95 citations

TREATMENT OF ACROMEGALY BY TRANS‐SPHENOIDAL OPERATION, 90‐YTTRIUM IMPLANTATION AND BROMOCRIPTINE: RESULTS IN 230 PATIENTS

1982 • 93 citations

Long Term Effects of Continuous Subcutaneous Infusion of the Somatostatin Analog Octreotide in the Treatment of Acromegaly

1989 • 92 citations

Acromegaly: Biochemical Assessment of Cure after Long Term Follow-Up of Transsphenoidal Selective Adenomectomy*

1985 • 87 citations

CONTINUOUS SUBCUTANEOUS PUMP INFUSION OF SOMATOSTATIN ANALOGUE SMS 201‐995 VERSUS SUBCUTANEOUS INJECTION SCHEDULE IN ACROMEGALIC PATIENTS

1987 • 87 citations

Pituitary microadenomas: diagnosis with two-and three-dimensional MR imaging at 1.5 T before and after injection of gadolinium.

1990 • 82 citations

Dose-Response Study and Long Term Effect of the Somatostatin Analog Octreotide in Patients with Therapy-Resistant Acromegaly*

1989 • 80 citations

Transsphenoidal surgery for acromegaly—long-term results in 100 patients

1985 • 71 citations

EFFECT OF SMS 201–995, A LONG‐ACTING SOMATOSTATIN ANALOGUE, ON THE SECRETION AND MORPHOLOGY OF A PITUITARY GROWTH HORMONE CELL ADENOMA

1987 • 56 citations

Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201–995 before transsphenoidal surgery

1994 • 56 citations

The Response of Serum Growth Hormone Levels to the Long-Acting Somatostatin Analog SMS 201-995 in Acromegaly

1987 • 54 citations

Growth hormone, growth factors, and acromegaly

1987 • 52 citations

Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations

1987 • 46 citations

Shrinking of a Growth Hormone-Producing Pituitary Tumor by Continuous Subcutaneous Infusion of the Somatostatin Analog SMS 201-995

1987 • 45 citations

Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor.Successful treatment with long-acting somatostatin analogue SMS 201–995

1988 • 44 citations

Therapeutic efficacy of a somatostatin analogue (SMS 201–995) in active acromegaly

1986 • 40 citations

Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor

1986 • 34 citations

Reversible Shrinkage of a Growth Hormone-Secreting Pituitary Adenoma by a Long-Acting Somatostatin Analogue, Octreotide

1989 • 31 citations

Comparison of the Effectiveness of 2-HourlyVersus8-Hourly Subcutaneous Injections of a Somatostatin Analog (SMS 201-995) in the Treatment of Acromegaly

1989 • 30 citations

CONTINUOUS INFUSION OF OCTREOTIDE IN ACROMEGALY

1989 • 25 citations

Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia, A variant of the McCune — Albright syndrome

1990 • 22 citations

Surgical Treatment of Acromegaly

1988 • 17 citations

Long-Term Efficacy of Sandostatin®(SMS 201–995, Octreotide) in 178 Acromegalic Patients. Results from the International Multicentre Acromegaly Study Group

1988 • 16 citations

Effects of somatostatin on somatotroph adenomas of the human pituitary: An in vitro functional and morphological study

1990 • 16 citations

Hypothalamic hormonal regulation of human growth hormone gene expression in somatotroph adenoma cell cultures

1990 • 14 citations

Effect of treatment with octreotide on the morphology of growth hormone—secreting pituitary adenomas: Study of 24 cases

1991 • 13 citations

Long-Term Management of Acromegaly with Sandostatin

1988 • 12 citations

Reversible shrinkage of a growth hormone-secreting pituitary adenoma by a long-acting somatostatin analogue, octreotide

1989 • 10 citations

Somatostatin Analog Treatment of Acromegaly: New Aspects

1988 • 9 citations

Treatment of prolactinomas and growth hormone-producing Adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump

1988 • 8 citations

Observations During a Clinical Trial of Sandostatin® in Acromegalic Patients

1988 • 7 citations

Experience with Sandostatin® in Various Groups of Acromegalic Patients

1988 • 6 citations

Size Changes of a Growth Hormone- and Prolactin-Producing Adenoma during and after Sandostatin Treatment

1988 • 6 citations

Continuous chronic intravenous application of SMS 201–995 via an implantable pump system in therapy-resistant acromegaly

1988 • 5 citations

Secretory Tumors of the Pituitary Gland

1986 • 1 citations

Deleted Work

1955 • 0 citations